Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
Autorzy:
François-Martin H; Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Lardy-Cléaud A; Centre Léon Bérard, Department of Biostatistics, 69008 Lyon, France. Pistilli B; Gustave Roussy Cancer Campus, Department of Medical Oncology, 94805 Villejuif, France. Levy C; Centre François Baclesse, Department of Medical Oncology, 14000 Caen, France. Diéras V; Centre Eugène Marquis, Department of Medical Oncology, 35000 Rennes, France. Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, 44800 Saint-Herblain, France. Guiu S; Department of Medical Oncology, Institut de Cancérologie de la Méditerranée, 34090 Montpellier, France. Mouret-ReynierMA; Centre Jean Perrin, Department of Medical Oncology, 63011 Clermont Ferrand, France. Mailliez A; Centre Oscar Lambret, Department of Medical Oncology, 59000 Lille, France. Eymard JC; Department of Medical Oncology, Institut Godinot, 51100 Reims, France. Petit T; Centre Paul Strauss, Department of Medical Oncology, 67200 Strasbourg, France. Ung M; Department of Medical Oncology, Institut Claudius Regaud, 31100 Toulouse, France. Desmoulins I; Centre Georges Francois Leclerc, Department of Medical Oncology, 21000 Dijon, France. Augereau P; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, 49055 Angers, France. Bachelot T; Centre Léon Bérard, Department of Medical Oncology, 69008 Lyon, France. Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, 54519 Nancy, France. Debled M; Department of Medical Oncology, Institut Bergonié, 33076 Bordeaux, France. Ferrero JM; Centre Antoine Lacassagne, Department of Medical Oncology, 06100 Nice, France. Clatot F; Centre Henri Becquerel, Department of Medical Oncology, 76038 Rouen, France. Goncalves A; Department of Medical Oncology, Institut Paoli Calmettes, 13009 Marseille, France. Chevrot M; Unicancer, Direction des Data, 75013 Paris, France. Chabaud S; Centre Léon Bérard, Department of Biostatistics, 69008 Lyon, France. Cottu P; Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Feb 13; Vol. 15 (4). Date of Electronic Publication: 2023 Feb 13.
Effectiveness of a Global Multidisciplinary Supportive and Educational Intervention in Thermal Resort on Anthropometric and Biological Parameters, and the Disease-Free Survival after Breast Cancer Treatment Completion (PACThe).
Autorzy:
Vasson MP; Jean Perrin Comprehensive Cancer Centre, Department of Nutrition, 58 Rue Montalembert, 63011 Clermont-Ferrand, France.; University of Clermont Auvergne, INRA, UMR 1019 Human Nutrition Unit, CRNH-Auvergne, 28 Place Henri Dunant, 63000 Clermont-Ferrand, France. Kwiatkowski F; Jean Perrin Comprehensive Cancer Centre, Department of Oncogenetics, 58 Rue Montalembert, 63011 Clermont-Ferrand, France.; University of Clermont-Auvergne, Laboratory of Mathematics, Probabilities and Applied Statistics, 28 Place Henri Dunant, 63000 Clermont-Ferrand, France. Rossary A; University of Clermont Auvergne, INRA, UMR 1019 Human Nutrition Unit, CRNH-Auvergne, 28 Place Henri Dunant, 63000 Clermont-Ferrand, France. Jouvency S; Jean Perrin Comprehensive Cancer Centre, Department of Nutrition, 58 Rue Montalembert, 63011 Clermont-Ferrand, France. Mouret-ReynierMA; Jean Perrin Comprehensive Cancer Centre, Department of Oncology, 58 Rue Montalembert, 63011 Clermont-Ferrand, France. Duclos M; Gabriel Montpied University Hospital, Department of Sport Medicine and Functional Explorations, 58 Rue Montalembert, 63000 Clermont-Ferrand, France. Van Praagh-Doreau I; Jean Perrin Comprehensive Cancer Centre, Department of Oncology, 58 Rue Montalembert, 63011 Clermont-Ferrand, France. Travade A; Centre République, Department of Senology, 99 Avenue de La Republique, 63100 Clermont Ferrand, France. Bignon YJ; Jean Perrin Comprehensive Cancer Centre, Department of Oncogenetics, 58 Rue Montalembert, 63011 Clermont-Ferrand, France.
Pokaż więcej
Źródło:
Journal of oncology [J Oncol] 2020 May 05; Vol. 2020, pp. 4181850. Date of Electronic Publication: 2020 May 05 (Print Publication: 2020).
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Autorzy:
Liang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. Briaux A; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. Becette V; Department of Biopathology, Curie Institute, René Huguenin Hospital, Saint-Cloud, France. Benoist C; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. Boulai A; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. Chemlali W; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. Schnitzler A; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, Curie Institute, PSL Research University, Paris, France. Rivera S; Department of Radiotherapy, Gustave Roussy, Villejuif, France. Mouret-ReynierMA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. Bouvet LV; Department of Medical Oncology, CHU, Limoges, France. De La Motte Rouge T; Department of Medical Oncology, Centre Eugene Marquis, Rennes, France. Lemonnier J; R&D Unicancer, UCBG, Paris, France. Lerebours F; Department of Medical Oncology, Curie Institute, René Huguenin Hospital, Saint-Cloud, France. Callens C; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, Paris, France. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2018 Oct 11; Vol. 11 (1), pp. 124. Date of Electronic Publication: 2018 Oct 11.
Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes.
Autorzy:
Gadéa E; a Clinical Research Unit , CH Emile Roux , Le Puy-en-Velay , France.; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France. Thivat E; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; c Centre d'Investigation Clinique , Clermont - Ferrand , France. Dubray-Longeras P; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; c Centre d'Investigation Clinique , Clermont - Ferrand , France. Arbre M; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France. Van-Praagh I; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; c Centre d'Investigation Clinique , Clermont - Ferrand , France. Mouret-ReynierMA; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; c Centre d'Investigation Clinique , Clermont - Ferrand , France. Herviou P; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; d Department of Pharmacology , CHU Clermont-Ferrand , Clermont-Ferrand , France. Dohou J; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; e Universite d'Auvergne , Clermont-Ferrand , France. Ginzac A; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; e Universite d'Auvergne , Clermont-Ferrand , France. Duclos M; f Department of Sport Medicine and Functional Explorations , CHU Clermont-Ferrand , Clermont-Ferrand , France.; g Human Nutrition Unit, INRA , Clermont-Ferrand , France. Morio B; e Universite d'Auvergne , Clermont-Ferrand , France.; g Human Nutrition Unit, INRA , Clermont-Ferrand , France. Durando X; b Clinical Research Unit, Centre Jean Perrin , Clermont-Ferrand , France.; c Centre d'Investigation Clinique , Clermont - Ferrand , France.
Pokaż więcej
Źródło:
Nutrition and cancer [Nutr Cancer] 2018 Oct; Vol. 70 (7), pp. 997-1006. Date of Electronic Publication: 2018 Sep 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.
Autorzy:
Hequet D; Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France.; INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France. Callens C; Department of Pharmacogenomics, Institut Curie, Paris, France. Gentien D; Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. Albaud B; Institut Curie, PSL Research University, Translational Research Department, Genomic platform, Paris, France. Mouret-ReynierMA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. Dubot C; Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. Cottu P; Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. Huchon C; Department of Gynecology, Poissy-St Germain hospital, Poissy, France. Zilberman S; Department of Gynecology, Tenon Hospital, Paris, France. Berseneff H; Department of Gynecology, René Dubos Hospital, Pontoise, France. Foa C; Department of Medical Oncology, Private Hospital Clairval, Marseille, France. Salmon R; Department of Surgery, Private Hospital Les Peupliers, Paris, France. Roulot A; Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. Lerebours F; Department of Medical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France. Salomon A; Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. Ghali N; NanoString Technologies, Inc., Seattle, WA, United States of America. Morel P; NanoString Technologies, Inc., Seattle, WA, United States of America. Li Q; Cedar Associates LLC, Menlo Park, CA, United States of America. Cayre A; Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. Guinebretière JM; Department of Pathology, Institut Curie-Centre René Huguenin, St Cloud, France. Hornberger J; NanoString Technologies, Inc., Seattle, WA, United States of America.; Stanford University School of Medicine, Department of Internal Medicine, Stanford, CA, United States of America. Penault-Llorca F; Department of Pathology, Centre Jean Perrin-UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. Rouzier R; Department of Surgical Oncology, Institut Curie-Centre René Huguenin, St Cloud, France.; INSERM-U900 -Bioinformatics, biostatistics, epidemiology and computational systems. Biology of cancer, St Cloud, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Oct 18; Vol. 12 (10), pp. e0185753. Date of Electronic Publication: 2017 Oct 18 (Print Publication: 2017).
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
Autorzy:
Lefebvre C; INSERM Unit U981, Gustave Roussy, Villejuif, France. Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. Filleron T; Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. Pedrero M; INSERM Unit U981, Gustave Roussy, Villejuif, France. Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. Soria JC; INSERM Unit U981, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France.; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Massard C; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Lévy C; Department of Medical Oncology, Centre François Baclesse, Caen, France. Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France. Lacroix-Triki M; INSERM Unit U981, Gustave Roussy, Villejuif, France. Garrabey J; R&D UNICANCER, Paris, France. Boursin Y; Bioinformatics core facility, Gustave Roussy, Villejuif, France. Deloger M; Bioinformatics core facility, Gustave Roussy, Villejuif, France. Fu Y; INSERM Unit U981, Gustave Roussy, Villejuif, France. Commo F; INSERM Unit U981, Gustave Roussy, Villejuif, France. Scott V; INSERM Unit U981, Gustave Roussy, Villejuif, France. Lacroix L; INSERM Unit U981, Gustave Roussy, Villejuif, France.; Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Kamal M; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. Diéras V; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Ferrerro JM; Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. Romieu G; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. Vanlemmens L; Department of Medical Oncology, Centre Oscar Lambret, Lille, France. MouretReynierMA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. Théry JC; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. Le Du F; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. Guiu S; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. Clapisson G; UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. Jimenez M; R&D UNICANCER, Paris, France. Le Tourneau C; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France.; EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. André F; INSERM Unit U981, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2016 Dec 27; Vol. 13 (12), pp. e1002201. Date of Electronic Publication: 2016 Dec 27 (Print Publication: 2016).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
